Sera Prognostics Releases Financial Results and Future Plans for Maternal Health Initiatives Sera Prognostics announces its financial results for 2025, showcasing advancements in maternal health technology and plans for commercial expansion.

Sera Prognostics Releases Financial Results and Future Plans for Maternal Health Initiatives #United_States #Salt_Lake_City #Sera_Prognostics #Maternal_Health #PreTRM_Test

Groundbreaking PreTRM Blood Test Helps Reduce Preterm Births and Newborn Issues A new study reveals that the PreTRM Test successfully decreases preterm births and enhances neonatal outcomes by using personalized screening.

Groundbreaking PreTRM Blood Test Helps Reduce Preterm Births and Newborn Issues #USA #Salt_Lake_City #Sera_Prognostics #PreTRM_Test #neonatal_health

Sera Prognostics Announces Major Publication Acceptance of PRIME Study Findings Sera Prognostics has announced the acceptance of the PRIME study findings for publication, focusing on preterm birth risk assessment to enhance maternal health.

Sera Prognostics Announces Major Publication Acceptance of PRIME Study Findings #USA #Salt_Lake_City #Sera_Prognostics #PreTRM_Test #PRIME_Study

Sera Prognostics Announces Financial Performance for Q3 2025 with Expansion Initiatives Sera Prognostics reports its third-quarter financial results for 2025, highlighting innovations in maternal health and expansion efforts in the U.S.

Sera Prognostics Announces Financial Performance for Q3 2025 with Expansion Initiatives #United_States #Salt_Lake_City #Sera_Prognostics #Maternal_Health #PreTRM_Test

Sera Prognostics Set to Present Innovations at Annual Investment Conference in New York Sera Prognostics will showcase its cutting-edge developments in maternal health at the upcoming H.C. Wainwright Global Investment Conference, September 5, 2025.

Sera Prognostics Set to Present Innovations at Annual Investment Conference in New York #United_States #New_York_City #Sera_Prognostics #Maternal_Health #PreTRM_Test

Sera Prognostics Reports Financial Results for Q2 2025 Reflecting Expansion in Maternal Health Solutions Sera Prognostics Inc. has released its financial results for the second quarter of 2025, highlighting significant progress in maternal health innovations and strategic successes.

Sera Prognostics Reports Financial Results for Q2 2025 Reflecting Expansion in Maternal Health Solutions #USA #Salt_Lake_City #Sera_Prognostics #PreTRM_Test #PRIME_Study

Sera Prognostics to Attend Multiple Upcoming Investor Conferences Focused on Maternal Health Sera Prognostics aims to enhance maternal and neonatal health through its participation in key investor conferences in early June 2025, highlighting innovative testing.

Sera Prognostics to Attend Multiple Upcoming Investor Conferences Focused on Maternal Health #United_States #Salt_Lake_City #Sera_Prognostics #Maternal_Health #PreTRM_Test

Sera Prognostics to Showcase Innovative Pregnancy Solutions at RBC Global Healthcare Conference Sera Prognostics will present groundbreaking advancements in maternal and neonatal health at the RBC Global Healthcare Conference, focusing on innovative pregnancy biomarker solutions.

Sera Prognostics to Showcase Innovative Pregnancy Solutions at RBC Global Healthcare Conference #United_States #Salt_Lake_City #Sera_Prognostics #Maternal_Health #PreTRM_Test

Sera Prognostics Welcomes Lee Anderson as Chief Commercial Officer to Drive Growth Sera Prognostics has appointed Lee Anderson as its Chief Commercial Officer, aiming to enhance maternal healthcare through innovative diagnostics and sales strategies.

Sera Prognostics Welcomes Lee Anderson as Chief Commercial Officer to Drive Growth #United_States #Salt_Lake_City #Sera_Prognostics #PreTRM_Test #Lee_Anderson

Sera Prognostics Reports Strong First Quarter Financial Performance for 2025 with Promising Outlook Sera Prognostics shares positive financial results for Q1 2025, enhancing focus on maternal health and exploring new market opportunities for its PreTRM Test.

Sera Prognostics Reports Strong First Quarter Financial Performance for 2025 with Promising Outlook #United_States #Salt_Lake_City #Sera_Prognostics #Maternal_Health #PreTRM_Test

Sera Prognostics Appoints Jeff Elliott to Board as Key Transitions Unfold Sera Prognostics Inc. welcomes Jeff Elliott to its board while Ryan Trimble and Marcus Wilson step down, signaling strategic changes ahead.

Sera Prognostics Appoints Jeff Elliott to Board as Key Transitions Unfold #United_States #Salt_Lake_City #Sera_Prognostics #PreTRM_Test #Jeff_Elliott

Sera Prognostics Unveils Financial Results and Expands Growth Strategy for Maternal Health Sera Prognostics reports fourth quarter 2024 earnings and key milestones achieved in neonatal care, while outlining future growth strategies.

Sera Prognostics Unveils Financial Results and Expands Growth Strategy for Maternal Health #United_States #Salt_Lake_City #Sera_Prognostics #Maternal_Health #PreTRM_Test

Sera Prognostics Announces Participation at TD Cowen 45th Annual Health Care Conference Sera Prognostics will present at the TD Cowen 45th Annual Health Care Conference, focusing on advancements in maternal and neonatal health.

Sera Prognostics Announces Participation at TD Cowen 45th Annual Health Care Conference #United_States #Salt_Lake_City #Sera_Prognostics #Health_Care #PreTRM_Test

Sera Prognostics Launches $50 Million Public Offering for Enhanced Maternal Healthcare Sera Prognostics, known for its innovative medical solutions, has announced a public offering totaling $50 million to advance maternal health initiatives.

Sera Prognostics Launches $50 Million Public Offering for Enhanced Maternal Healthcare #United_States #Salt_Lake_City #Sera_Prognostics #PreTRM #maternal_healthcare

Sera Prognostics Unveils Plans for New Public Offering to Accelerate Growth in Maternal Healthcare Sera Prognostics, Inc. has announced a proposed public offering to enhance maternal and neonatal health initiatives in the USA and Europe, boosting their innovative efforts.

Sera Prognostics Unveils Plans for New Public Offering to Accelerate Growth in Maternal Healthcare #United_States #Salt_Lake_City #Sera_Prognostics #Maternal_Health #PreTRM_Test

Sera Prognostics to Showcase Innovations at J.P. Morgan Healthcare Conference 2025 Sera Prognostics is set to present its innovative maternal health solutions at the upcoming J.P. Morgan Healthcare Conference in San Francisco.

Sera Prognostics to Showcase Innovations at J.P. Morgan Healthcare Conference 2025 #United_States #San_Francisco #Sera_Prognostics #Maternal_Health #PreTRM_Test

Sera Prognostics Set to Reveal PRIME Study Insights at 2025 SMFM Event Sera Prognostics will present key findings from its PRIME study at the 2025 SMFM Pregnancy Meeting, showcasing innovative prenatal health solutions aimed at improving outcomes.

Sera Prognostics Set to Reveal PRIME Study Insights at 2025 SMFM Event #USA #Salt_Lake_City #Sera_Prognostics #Pregnancy_Health #Neonatal_Outcomes